Phase II feasibility study of adjuvant S-1 plus CPT-11 for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0801).

被引：0
|
作者：
Kimura, Yutaka
Fujitani, Kazumasa
Ueda, Shugo
Taniguchi, Hirokazu
Imamura, Hiroshi
Gofuku, Junji
Tamura, Shigeyuki
Kurokawa, Yukinori
Takiuchi, Hiroya
Furukawa, Hiroshi
机构：
[1] NTT West Osaka Hosp, Dept Surg, Osaka, Japan
[2] Osaka Natl Hosp, Osaka, Japan
[3] Kitano Hosp, Dept Surg, Osaka, Japan
[4] NTT West Osaka Hosp, Osaka, Japan
[5] Sakai Municipal Hosp, Sakai, Osaka, Japan
[6] Kaizuka Municipal Hosp, Dept Surg, Kaizuka, Japan
[7] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[8] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan
[9] Osaka Med Coll, Osaka, Japan
[10] Sakai Municipal Hosp, Dept Surg, Sakai, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase I study of irinotecan (CPT-11) combined with S-1 in patients with advanced gastric cancer(AGC)
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 253 - 254
  • [42] Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer
    Serrano, Mariana
    Araujo, Jhajaira M.
    Pacheco, Cristian
    Macetas, Jackeline
    Blum, Mariella A.
    Carrato, Alfredo
    Ruiz, Eloy
    Berrospi, Francisco
    Luque, Carlos
    Chavez, Ivan
    Payet, Eduardo
    Taxa, Luis
    Montenegro, Paola
    ECANCERMEDICALSCIENCE, 2022, 16
  • [43] A phase II study to examine the effectiveness of nutritional support with elemental diet for stage II/III gastric cancer patients receiving adjuvant chemotherapy with S-1 (OGSG 1108).
    Kawada, Junji
    Imamura, Hiroshi
    Matsuyama, Jin
    Fukui, Junichi
    Nishikawa, Kazuhiro
    Kawase, Tomono
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [44] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP.
    Kawase, Tomono
    Imamura, Hiroshi
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawabata, Ryohei
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Sakai, Daisuke
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Feasibility of adjuvant S-1 plus docetaxel against stage II-III gastric cancer following R0 resection in gastrectomy
    Emi, Y.
    Orita, H.
    Yamamoto, M.
    Sadanaga, T.
    Kusumoto, T.
    Takahashi, I.
    Kakeji, Y.
    Maehara, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 372 - 372
  • [46] FIVE-YEAR RESULTS OF THE RANDOMIZED PHASE III TRIAL COMPARING S-1 MONOTHERAPY VERSUS SURGERY ALONE FOR STAGE II/III GASTRIC CANCER PATIENTS AFTER CURATIVE D2 GASTRECTOMY (ACTS-GC STUDY)
    Sasako, M.
    Kinoshita, T.
    Furukawa, H.
    Yamaguchi, T.
    Nashimoto, A.
    Fujii, M.
    Nakajima, T.
    Ohashi, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 225 - 225
  • [47] Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
    Takahashi, Ryo
    Ohashi, Manabu
    Kano, Yosuke
    Ida, Satoshi
    Kumagai, Koshi
    Nunobe, Souya
    Chin, Keisho
    Yamaguchi, Kensei
    Nagino, Masato
    Sano, Takeshi
    Hiki, Naoki
    GASTRIC CANCER, 2019, 22 (06) : 1256 - 1262
  • [48] Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
    Ryo Takahashi
    Manabu Ohashi
    Yosuke Kano
    Satoshi Ida
    Koshi Kumagai
    Souya Nunobe
    Keisho Chin
    Kensei Yamaguchi
    Masato Nagino
    Takeshi Sano
    Naoki Hiki
    Gastric Cancer, 2019, 22 : 1256 - 1262
  • [49] Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1
    Toru Aoyama
    Takaki Yoshikawa
    Takafumi Watanabe
    Tsutomu Hayashi
    Takashi Ogata
    Haruhiko Cho
    Akira Tsuburaya
    Gastric Cancer, 2011, 14 : 274 - 278
  • [50] Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1
    Aoyama, Toru
    Yoshikawa, Takaki
    Watanabe, Takafumi
    Hayashi, Tsutomu
    Ogata, Takashi
    Cho, Haruhiko
    Tsuburaya, Akira
    GASTRIC CANCER, 2011, 14 (03) : 274 - 278
12345